Policy on drug misuse in Europe

Michael Farrell(UNSW Sydney), Peter Reuter(RAND Corporation), Jan Neeleman(Arkin), John Strang(King's College London)

BMJ

March 5, 1994

10.1136/bmj.308.6929.609

Cited by 9

Related Papers

Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma

|Cancer Cell|2017|1.3k

Risk factors for suicidality in Europe: Results from the ESEMED study

|Journal of Affective Disorders|2006|571

Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database

|Nature Genetics|2013|476

The efficacy of single‐session motivational interviewing in reducing drug consumption and perceptions of drug‐related risk and harm among young people: results from a multi‐site cluster randomized trial

|Addiction|2003|448

Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study

|BMJ|2003|338